Dr Ken Gillman
Critical independent evaluations in psycho-pharmacology
MENU
Duloxetine does not have a ‘badge-engineered’ metabolite derivative to extend its patent, unlike Venlafaxine (Effexor, now out of patent), and its patent-extending-metabolite, desvenlafaxine.This commentary will be short because it is…
Venlafaxine (Effexor, now out of patent) and its ‘badge-engineered’ metabolite off-spring (desvenlafaxine, Pristiq- in patent, which is even weaker than venlafaxine as an NRI) are examples of drugs whose attribution…
Date Created: about 1998Preface to ‘old edition’Most of the SNRIs that have been on the market have failed to show antidepressant effect in most trials. This drug is a reminder…
PsychoTropical is a knowledge and education resource started by Dr Gillman about 20 years ago. It is neither connected with, nor influenced by, any financial backing or interest group of any sort. The opinions expressed relate to Dr Gillman’s special knowledge and expertise as a recognised world-expert in MAOIs and serotonin toxicity.
© PsychoTropical 2023. All Rights Reserved